Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred? Meeting Abstract


Authors: Omuro, A.; Abrey, L.; Raizer, J.; Paleologos, N.; Forsyth, P.; DeAngelis, L.; Kaley, T.; Louis, D.; Cairncross, J. G.; Matasar, M.; Mehta, J.; Grimm, S.; Moskowitz, C.; Sauter, C.
Abstract Title: Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
Meeting Title: 4th Quadrennial Meeting of the World Federation of Neuro-Oncology (WFNO)/18th Annual Meeting of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 15
Issue: Suppl. 3
Meeting Dates: 2013 Nov 21-24
Meeting Location: San Francisco, CA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2013-11-01
Start Page: iii125
Language: English
ACCESSION: WOS:000327456200500
PROVIDER: wos
DOI: 10.1093/neuonc/not182
PMCID: PMC3823897
Notes: Meeting Abstract: NO-108 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Craig Moskowitz
    406 Moskowitz
  2. Antonio Marcilio Padula Omuro
    204 Omuro
  3. Thomas Kaley
    142 Kaley
  4. Craig Steven Sauter
    332 Sauter
  5. Lauren E Abrey
    277 Abrey
  6. Matthew J Matasar
    284 Matasar